ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.460
+0.040 (1.65%)
Aug 3, 2026, 11:38 AM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €38.89 million as of August 3, 2026. Its market cap has decreased by -52.68% in one year.
Market Cap
38.89M
Enterprise Value
39.82M
Revenue
7.97M
Ranking
n/a
PE Ratio
40.33
Stock Price
€2.46
ChartMarket Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 38.89M, an increase of 1,450.49%. That is a compound annual growth rate of 11.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 38.89M | -19.56% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 89.52B |
| EssilorLuxottica Société anonyme | 75.40B |
| Sartorius Stedim Biotech | 16.22B |
| Ipsen | 13.71B |
| Klea Holding | 47.95M |
| Fermentalg | 44.28M |
| S.M.A.I.O | 43.37M |
| AB Science | 43.29M |